Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

6.00
Delayed Data
As of Oct 19
 -0.05 / -0.83%
Today’s Change
3.30
Today|||52-Week Range
6.70
+10.09%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close6.05
Today’s open6.05
Day’s range5.95 - 6.05
Volume105,110
Average volume (3 months)144,975
Market cap$168.8M
Dividend yield--
Data as of 10/19/2017

Growth & Valuation

Earnings growth (last year)-42.42%
Earnings growth (this year)+39.15%
Earnings growth (next 5 years)--
Revenue growth (last year)+98.84%
P/E ratioNM
Price/Sales14.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp-0.03-0.71%
NVLNNovelion Therapeutic...-0.05-0.76%
CDTXCidara Therapeutics ...+0.55+8.66%
NATRNatures Sunshine Pro...-0.15-1.46%
Data as of 10/19/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$9.5M
Annual profit (last year)-$11.9M
Net profit margin-125.31%

Profile

Sector
Health Technology
Industry
Medical Specialties
President Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent J. Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts